Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sunobinop for alcohol use disorder
2024-517105-85-00Phase 2Completed
- Sponsor
- Knoa Pharma
- Start
- May 2025
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 2, randomised, double-blind trial of sunobinop in alcohol use disorder (AUD) (4 arms), sponsored by Knoa Pharma. Primary endpoint: Percent heavy drinking days. Started May 2025; status: completed.
02
Drugs
sunobinop
03
Conditions
alcohol use disorder (AUD)
Beyond the preview
Go deeper on 2024-517105-85-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-517105-85-00.